To unlock this video you need to become a Bronze, Silver, Gold, Bronze extended, Silver extended, Gold extended, Bronze – fr, Bronze extended – fr, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Member.
Check Our CME Program
Unlock this Video Lecture and earn 1.00 CMEs
Become a Bronze, Silver, Gold, Bronze extended, Silver extended, Gold extended, Bronze – fr, Bronze extended – fr, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Member.
Already have an account? Sign in
Learning Objectives:
After completing this activity, the learner will be able to:
Original Release Date: October 8, 2019
Expiration Date: March 31, 2022
Martha Sajatovic declares the following interests:
- Otsuka, Alkermes, Janssen, International Society for Bipolar Disorders, Reuter Foundation, Woodruff Foundation, Reinberger Foundation, National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC): Contracted research
- Alkermes, Bracket, Otsuka, Janssen, Neurocrine, Health Analytics, Frontline Medical Communications: Consulting activities
- Springer Press, Johns Hopkins University Press, Oxford Press, UpToDate: Publications
- American Physician?s Institute, MCM Education, CMEology, Potomac Center for Medical Education, Global Medical Education, Creative Educational Concepts, Psychopharmacology Institute: Development of CME materials
All of the relevant financial relationships listed above have been mitigated by Medical Academy and the Psychopharmacology Institute.
Contact Information: For questions regarding the content or access to this activity, contact us at support@ml-prod.psychopharmacologyinstitute.com
Become a Bronze, Silver, Gold, Bronze extended, Silver extended, Gold extended, Bronze – fr, Bronze extended – fr, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Member.
2025–26 Psychopharmacology CME Program
